PSNC sets up Community Pharmacy Brexit Forum

PSNC sets up Community Pharmacy Brexit Forum

July 27 2018 Chief executives of representative bodies involved in community pharmacy and the...

Boots and PDA discuss union recognition, but no agreement as yet

Boots and PDA discuss union recognition, but no agreement as yet

July 26 2018 The Pharmacists’ Defence Association has been holding talks with members of...

Appeal process for overpayment recovery by NHS England to start in August

Appeal process for overpayment recovery by NHS England to start in August

July 26 2018 New regulations introducing an appeals process to challenge NHS England recovering...

MPs hear about community pharmacy role in LTC management

MPs hear about community pharmacy role in LTC management

July 20 2018 Community pharmacy representatives have briefed MPs about the role pharmacy teams...

MHRA launches consultation on implementing FMD safety features

MHRA launches consultation on implementing FMD safety features

July 20 2018 A consultation asking for views on how the safety features required under the...

  • PSNC sets up Community Pharmacy Brexit Forum

    PSNC sets up Community Pharmacy Brexit Forum

    Friday, 27 July 2018 16:04
  • Boots and PDA discuss union recognition, but no agreement as yet

    Boots and PDA discuss union recognition, but no agreement as yet

    Thursday, 26 July 2018 15:19
  • Appeal process for overpayment recovery by NHS England to start in August

    Appeal process for overpayment recovery by NHS England to start in August

    Thursday, 26 July 2018 15:04
  • MPs hear about community pharmacy role in LTC management

    MPs hear about community pharmacy role in LTC management

    Friday, 20 July 2018 16:30
  • MHRA launches consultation on implementing FMD safety features

    MHRA launches consultation on implementing FMD safety features

    Friday, 20 July 2018 14:41

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

a scottish flag image cbNovember 13 2017

Details of Pharmacy Services remuneration for 2017-18 have been published by the Scottish Government. 

Key points noted in NHS Circular PCA (P)(2017) 13 are that:

  • the Global Sum will remain unchanged at £178.359 million for the financial year 2017-18;
  • the non-Global Sum shall roll forward at its current level of £1.3 million;
  • the guaranteed minimum margin retained by contractors be increased to £110 million;
  • that should market conditions permit, contractors be allowed the opportunity to retain 100% of margin up to £10 million, above the guaranteed minimum margin;
  • that any margin earned above £120 million will be shared on a 50:50 basis with NHS Boards;
  • a reduction in the value of reimbursement prices of generic drugs listed in Part 7 of the Drug Tariff totalling £20 million, achieved over a 12-month period, effective from 1 June 2017;
  • effective from 1 June 2017, the generic clawback to be reset to zero for the remainder of the financial year;
  • NHS Boards will reinvest £2 million into the pharmacy network to support service development as outlined in the 2016-17 agreement.

The settlement takes into account further changes introduced since July. The settlement has been agreed with Community Pharmacy Scotland.

The NHS Circular also sets out details for individual payments for specific services such as the Chronic Medication Service and Minor Ailments Services, establishment payments, care bundles, and public health services.

Link:
NHS Circular PCA (P)(2017) 13 ‘Pharmaceutical Services: amendments to drug tariff in respect of remuneration arrangements from 1 April 2017’                  

Business News

July 31 2018 General practices employing pharmacists are citing improved capacity to see patients and workload changes as the main benefits of the scheme.
July 25 2018 Switching to sulfonylureas in type 2 diabetes has been linked with an increased risk of complications compared with staying on metformin, a BMJ study has concluded. However, the study has...